EP Patent

EP1093371B1 — Use of fk506 and related macrolides in the manufacture of a medicament for treatment or prevention of pain

Assigned to Fujisawa Pharmaceutical Co Ltd · Expires 2005-05-25 · 21y expired

What this patent protects

Macrolide compounds, such as the FK506 Substance and its related compounds are provided for use as an analgesic, particularly, a topical analgesic. Composition containing such compounds is also disclosed.

USPTO Abstract

Macrolide compounds, such as the FK506 Substance and its related compounds are provided for use as an analgesic, particularly, a topical analgesic. Composition containing such compounds is also disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP1093371B1
Jurisdiction
EP
Classification
—
Expires
2005-05-25
Drug substance claim
No
Drug product claim
No
Assignee
Fujisawa Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.